Literature DB >> 27141884

Integrated analysis of multidimensional omics data on cutaneous melanoma prognosis.

Yu Jiang1, Xingjie Shi2, Qing Zhao3, Michael Krauthammer4, Bonnie E Gould Rothberg5, Shuangge Ma6.   

Abstract

Multiple types of genetic, epigenetic, and genomic changes have been implicated in cutaneous melanoma prognosis. Many of the existing studies are limited in analyzing a single type of omics measurement and cannot comprehensively describe the biological processes underlying prognosis. As a result, the obtained prognostic models may be less satisfactory, and the identified prognostic markers may be less informative. The recently collected TCGA (The Cancer Genome Atlas) data have a high quality and comprehensive omics measurements, making it possible to more comprehensively and more accurately model prognosis. In this study, we first describe the statistical approaches that can integrate multiple types of omics measurements with the assistance of variable selection and dimension reduction techniques. Data analysis suggests that, for cutaneous melanoma, integrating multiple types of measurements leads to prognostic models with an improved prediction performance. Informative individual markers and pathways are identified, which can provide valuable insights into melanoma prognosis.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Integration; Melanoma prognosis; Multidimensional omics data; The Cancer Genome Atlas (TCGA)

Mesh:

Substances:

Year:  2016        PMID: 27141884      PMCID: PMC4893887          DOI: 10.1016/j.ygeno.2016.04.005

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  40 in total

1.  Improved survival with MEK inhibition in BRAF-mutated melanoma.

Authors:  Keith T Flaherty; Caroline Robert; Peter Hersey; Paul Nathan; Claus Garbe; Mohammed Milhem; Lev V Demidov; Jessica C Hassel; Piotr Rutkowski; Peter Mohr; Reinhard Dummer; Uwe Trefzer; James M G Larkin; Jochen Utikal; Brigitte Dreno; Marta Nyakas; Mark R Middleton; Jürgen C Becker; Michelle Casey; Laurie J Sherman; Frank S Wu; Daniele Ouellet; Anne-Marie Martin; Kiran Patel; Dirk Schadendorf
Journal:  N Engl J Med       Date:  2012-06-04       Impact factor: 91.245

Review 2.  Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.

Authors:  Gajanan S Inamdar; SubbaRao V Madhunapantula; Gavin P Robertson
Journal:  Biochem Pharmacol       Date:  2010-05-09       Impact factor: 5.858

3.  Long-term survival in patients with metastatic melanoma treated with DTIC or temozolomide.

Authors:  Christina Kim; Christopher W Lee; Laurel Kovacic; Amil Shah; Richard Klasa; Kerry J Savage
Journal:  Oncologist       Date:  2010-06-10

4.  Screening biomarkers of prostate cancer by integrating microRNA and mRNA microarrays.

Authors:  Jiayu Feng; Chibing Huang; Xinwei Diao; Minqi Fan; Pingxian Wang; Ya Xiao; Xiao Zhong; Ronghua Wu
Journal:  Genet Test Mol Biomarkers       Date:  2013-08-28

5.  survcomp: an R/Bioconductor package for performance assessment and comparison of survival models.

Authors:  Markus S Schröder; Aedín C Culhane; John Quackenbush; Benjamin Haibe-Kains
Journal:  Bioinformatics       Date:  2011-09-07       Impact factor: 6.937

6.  A novel oncogenic role for the miRNA-506-514 cluster in initiating melanocyte transformation and promoting melanoma growth.

Authors:  K L Streicher; W Zhu; K P Lehmann; R W Georgantas; C A Morehouse; P Brohawn; R A Carrasco; Z Xiao; D A Tice; B W Higgs; L Richman; B Jallal; K Ranade; Y Yao
Journal:  Oncogene       Date:  2011-08-22       Impact factor: 9.867

7.  Association between BRAFV600E and NRASQ61R mutations and clinicopathologic characteristics, risk factors and clinical outcome of primary invasive cutaneous melanoma.

Authors:  Shaowei Wu; Helen Kuo; Wen-Qing Li; Alvaro Laga Canales; Jiali Han; Abrar A Qureshi
Journal:  Cancer Causes Control       Date:  2014-07-22       Impact factor: 2.506

Review 8.  The role of the PI3K-AKT pathway in melanoma.

Authors:  Michael A Davies
Journal:  Cancer J       Date:  2012 Mar-Apr       Impact factor: 3.360

Review 9.  Staging and prognosis of cutaneous melanoma.

Authors:  Paxton V Dickson; Jeffrey E Gershenwald
Journal:  Surg Oncol Clin N Am       Date:  2011-01       Impact factor: 3.495

Review 10.  Signal transduction in human cutaneous melanoma and target drugs.

Authors:  Anatoly B Uzdensky; Svetlana V Demyanenko; Mikhail Y Bibov
Journal:  Curr Cancer Drug Targets       Date:  2013-10       Impact factor: 3.428

View more
  26 in total

1.  Analysis of cancer gene expression data with an assisted robust marker identification approach.

Authors:  Hao Chai; Xingjie Shi; Qingzhao Zhang; Qing Zhao; Yuan Huang; Shuangge Ma
Journal:  Genet Epidemiol       Date:  2017-09-14       Impact factor: 2.135

2.  Identification of cancer omics commonality and difference via community fusion.

Authors:  Yifan Sun; Yu Jiang; Yang Li; Shuangge Ma
Journal:  Stat Med       Date:  2018-11-12       Impact factor: 2.373

3.  Multi-kernel linear mixed model with adaptive lasso for prediction analysis on high-dimensional multi-omics data.

Authors:  Jun Li; Qing Lu; Yalu Wen
Journal:  Bioinformatics       Date:  2020-03-01       Impact factor: 6.937

4.  Identifying gene-gene interactions using penalized tensor regression.

Authors:  Mengyun Wu; Jian Huang; Shuangge Ma
Journal:  Stat Med       Date:  2017-10-16       Impact factor: 2.373

Review 5.  Statistical genomics in rare cancer.

Authors:  Farnoosh Abbas-Aghababazadeh; Qianxing Mo; Brooke L Fridley
Journal:  Semin Cancer Biol       Date:  2019-08-19       Impact factor: 15.707

6.  The Immunogenetics of Melanoma.

Authors:  Farzaneh Darbeheshti
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

7.  Structured Analysis of the High-dimensional FMR Model.

Authors:  Mengque Liu; Qingzhao Zhang; Kuangnan Fang; Shuangge Ma
Journal:  Comput Stat Data Anal       Date:  2019-11-13       Impact factor: 1.681

8.  Integration of Proteomics and Other Omics Data.

Authors:  Mengyun Wu; Yu Jiang; Shuangge Ma
Journal:  Methods Mol Biol       Date:  2021

9.  Multidimensional molecular measurements-environment interaction analysis for disease outcomes.

Authors:  Yaqing Xu; Mengyun Wu; Shuangge Ma
Journal:  Biometrics       Date:  2021-07-02       Impact factor: 1.701

10.  Biomarker-guided heterogeneity analysis of genetic regulations via multivariate sparse fusion.

Authors:  Sanguo Zhang; Xiaonan Hu; Ziye Luo; Yu Jiang; Yifan Sun; Shuangge Ma
Journal:  Stat Med       Date:  2021-04-27       Impact factor: 2.497

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.